Baek Sun Kyung, Lee Ji Sung, Hwang In Gyu, Kim Jong Gwang, Kim Tae Won, Sohn Seung Kook, Kang Mi Yeon, Lee Sang-Cheol
Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea.
Clinical Research Center, Asan Medical Center, Seoul, Korea.
Korean J Intern Med. 2021 Jul;36(4):985-991. doi: 10.3904/kjim.2019.066. Epub 2021 Apr 6.
BACKGROUND/AIMS: This nationwide study was undertaken to determine differences in clinicopathologic characteristics and survival of patients with colorectal cancer (CRC) according to age using big data from the Korean National Health Insurance Service (NHIS).
The NHIS data including quality assessment of CRC by the Health Insurance Review & Assessment Service in Korea between 2011 and 2014 were analyzed. Based on age, patients were divided into three groups: not-old patients (< 65), young-old patients (65 to 74 years old) and old-old patients (≥ 75 years old).
We included 71,513 CRC patients. The median follow-up duration was 3.2 years (range, 0.003 to 5.5). Male patients constituted 60%. The median age of patients was 65 years (range, 18 to 102). Colon was the cancer site in 59.8% of not-old patients, 62.9% of young-old patients, and 66.1% of old-old patients. Compared to not-old patients, young-old and old-old patients were more likely to be diagnosed with colon adenocarcinoma and well/moderate differentiation or adequate differentiation (all p < 0.001). Old patients underwent more emergency operation (p < 0.001) and received less adjuvant therapy in stage I-III (p < 0.001). The probability of 3-year survival of young-old or old-old patients was worse than that for not-old patients (hazard ratio [HR], 1.55; 95% confidence interval [CI], 1.46 to 1.64) (HR, 3.19; 95% CI, 3.03 to 3.37).
Old patients with CRC show different histology from younger patients. They are more frequently to have colon as primary lesion. They undergo less adjuvant therapy. Further studies and evidence-based guidelines for older patients with CRC are warranted to improve their outcome.
背景/目的:本全国性研究旨在利用韩国国民健康保险服务(NHIS)的大数据,确定不同年龄的结直肠癌(CRC)患者在临床病理特征和生存方面的差异。
分析了2011年至2014年韩国健康保险审查与评估服务机构对CRC进行质量评估的NHIS数据。根据年龄,患者分为三组:非老年患者(<65岁)、年轻老年患者(65至74岁)和老年老年患者(≥75岁)。
我们纳入了71513例CRC患者。中位随访时间为3.2年(范围,0.003至5.5年)。男性患者占60%。患者的中位年龄为65岁(范围,18至102岁)。非老年患者中59.8%的癌症部位在结肠,年轻老年患者中为62.9%,老年老年患者中为66.1%。与非老年患者相比,年轻老年和老年老年患者更有可能被诊断为结肠腺癌以及高/中分化或充分分化(所有p<0.001)。老年患者接受急诊手术的比例更高(p<0.001),在I-III期接受辅助治疗的比例更低(p<0.001)。年轻老年或老年老年患者的3年生存率低于非老年患者(风险比[HR],1.55;95%置信区间[CI],1.46至1.64)(HR,3.19;95%CI,3.03至3.37)。
老年CRC患者的组织学表现与年轻患者不同。他们更常以结肠作为原发病变。他们接受的辅助治疗较少。有必要针对老年CRC患者开展进一步研究并制定基于证据的指南,以改善其治疗效果。